Comeback season for the IPO?
There’s been a lot of exit talk over the past year with the emergence of the SPAC as a popular vehicle. But the trusty ol’ IPO hasn’t totally gone out of style, as demonstrated by Noom and Sophia Genetics last week. With all of the buzz around digital health startups exiting, we were curious—how are public digital health companies actually faring in the markets? We found that, on average, companies that recently exited to the public markets (since January 2020) had their Q2 2021 returns fall below NASDAQ levels. On the flip side, digital health companies that have been public for longer than 18 months had their average returns track or even beat the NASDAQ for all of H1. In the Monday spirit, it might just take some time for everyone to find their groove.
Headlines
The Most Intriguing Health Tech Deals Of The Year (So Far)
A breakdown of digital health’s H1 movers and shakers STAT
CMS Proposes To Expand The Home Health Value-Based Purchasing Model
Digital health can play a huge role Healthcare Finance News
Amazon Care In Talks With Health Insurers To Go In Network
The prospect of scale has the disruptor hoping to play nice with incumbents Business Insider
Digital Health Investment Boom Speeds Ahead With First-Half Jump
ICYMI: a record $14.7B was invested in H1 Bloomberg
Recent Funding
- Thrive Global, which offers digital well-being and stress resilience coaching, nets $80M
- AI precision medicine approach for cancer treatment Xilis lands $70M
- Linus Health rakes in $55M to expand its digital screening and monitoring tools for Alzheimer's
- uLab, a dental treatment planning software, brings in $54.5M
- Osso VR, which designs virtual reality modules for surgical training, adds $27M
- Assured Allies, a platform that helps link seniors to health services, secures $18.3M
- Medication price transparency network RxRevu grabs $8M
- Connected fitness company Arena closes on $5.2M
- Virtual MSK clinic Vori Health bags $5M